Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Proteomic Analyses Identify Therapeutic Targets in Hepatocellular Carcinoma

Frontiers in Oncology(2022)10.3389/fonc.2022.814120Source: DataRank Database

Proteomic Analyses Identify Therapeutic Targets in Hepatocellular Carcinoma is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.76)OA: goldTopics (35)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Amaia Lujambio ORCID,Kuan‐lin Huang ORCID,Abdülkadir Elmas ORCID

Live enrichment

PubMed:35433463 PMC:PMC9006883 OpenAlex:https://openalex.org/W4220918242

Office of Extramural Research, National Institutes of Health

Grant: R35GM138113

National Institutes of Health

Grant: 1P30CA196521-01

Mouse Genetics

National Institutes of Health

Grant: 4R37CA230636-06

Tumor-intrinsic signaling pathways restrict anti-tumor immunity in hepatocellular carcinoma

National Institutes of Health

Grant: 5R35GM138113-03

Integrative Approaches for Identifying Causal Gene-Cell Type Pairs of Complex Disease

FWCI

0.76

Citation Percentile

0.6%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3389/fonc.2022.814120

publisherhttps://doi.org/10.3389/fonc.2022.814120

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2022.814120/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35433463

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9006883

Fields of Study

Cancer, Hypoxia, and MetabolismCancer, Lipids, and MetabolismHepatocellular Carcinoma Treatment and Prognosis0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Hepatocellular carcinomaProteomicsCancer researchDruggabilityMedicinePDGFRBCyclin-dependent kinase 6CancerPrecision medicineTranscriptomeProteomeTargeted therapyComputational biologyKinomeBioinformaticsBiologyKinaseInternal medicinePathologyGeneGeneticsGene expressionCell cycleCyclin-dependent kinaseProteogenomicsPrecision OncologyOncologyNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being